Get an alert when HYPERLIPIDAEMIA EDUCATION & ATHEROSCLEROSIS RESEARCH TRUST UK files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-11-30 (in 6mo)

Last filed for 2025-02-28

Confirmation statement due

2026-08-02 (in 3mo)

Last made up 2025-07-19

Watchouts

1 item

Cash

£628K

-5.4% vs 2024

Net assets

£644K

+15.5% vs 2024

Employees

6

-14.3% vs 2024

Profit before tax

£84K

+216.2% vs 2024

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Name history

Renamed 2 times since incorporation

  1. HYPERLIPIDAEMIA EDUCATION & ATHEROSCLEROSIS RESEARCH TRUST UK 2006-07-19 → present
  2. HYPERLIPIDAEMIA EDUCATION AND RESEARCH TRUST UK 2002-07-05 → 2006-07-19
  3. THE FAMILY HEART ASSOCIATION 1991-07-19 → 2002-07-05

Accounts

2-year trend · latest reflected 2025-02-28

Metric Trend 2024-02-292025-02-28
Turnover £779,622£756,156
Operating profit -£79,034£74,956
Profit before tax -£72,274£83,957
Net profit -£72,274£83,957
Cash £664,372£628,368
Total assets less current liabilities £557,356£644,019
Net assets £557,356£644,019
Equity £557,356£644,019
Average employees 76
Wages £348,093£354,794

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-02-292025-02-28
Operating margin -10.1%9.9%
Net margin -9.3%11.1%
Return on capital employed -14.2%11.6%
Gearing (liabilities / total assets) 43.8%42.6%
Current ratio 2.10x2.18x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Consolidated group
Auditor
Moore Kingston Smith LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The company continues to adopt the going concern basis in preparing its financial statements. The trustees have assessed whether the use of the going concern basis is appropriate and have considered possible events or conditions that might cast significant doubt on the ability of the company to continue as a going concern. The trustees have made this assessment for a period of at least one year from the date of approval of the financial statements.”

Group structure

  1. HYPERLIPIDAEMIA EDUCATION & ATHEROSCLEROSIS RESEARCH TRUST UK · parent
    1. HEART UK Trading Company Limited 100% · UK · trading subsidiary of the group

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

14 active · 56 resigned

Name Role Appointed Born Nationality
PAYNE, Julie Dawn Secretary 2010-08-01
BENNETT, Joanne Director 2013-10-02 Feb 1977 British
DATTA, Dev Borunendra Nath, Dr Director 2018-07-18 Aug 1974 British
DIXON, Thomas Matthew Director 2018-08-31 Mar 1980 British
DOBSON, Bryan Andrew Director 2017-04-20 Jan 1974 British
GREAVES, Andrew Jeffery Director 2018-03-07 Mar 1965 British
GREEN, Peter Huw, Dr Director 2017-05-11 Nov 1960 British
HARRISON, Andrew David Director 2024-12-12 Aug 1971 British
HUGHES, Elizabeth Ann, Professor Director 2013-12-19 Jan 1957 British
NEELY, Dermot, Dr Director 2011-07-11 Jan 1958 British
PHIPPS, Neil Robert Director 2018-07-24 Apr 1955 British
POTTLE, Alison Director 2018-08-13 Mar 1963 British
REES, John Alan Evan, Doctor Director 2007-02-19 Sep 1951 British
SORAN, Handrean, Dr Director 2020-03-12 Apr 1968 British
Show 56 resigned officers
Name Role Appointed Resigned
GOLDWATER, Michael Harry Secretary 1993-04-19 1994-06-15
LIVINGSTON, Michael Stuart Secretary 1997-09-01 2010-07-12
STEELE, Donald William Secretary 1991-07-19 1993-03-31
TURNER, Michael Rex, Doctor Secretary 1994-06-15 1997-08-31
BARRETT, Anthony John Walter Director 1991-07-19 1992-10-30
BEAVEN-TAYLOR, Sylvia Frances Director 1997-11-22 2001-12-06
BENDER, Clive Bernard Director 1999-11-26 2002-01-01
BOLEY, Stephen David Director 2010-10-04 2023-07-05
BRAIN, Roger Director 1997-11-01 1999-11-26
BROOME, Katharine Director 2002-06-28 2004-03-08
CAMPBELL, Dalhia Director 1997-11-01 2001-12-06
CONNOR, Hazel Mary Director 1991-07-19 1997-04-10
CRAMB, Robert, Dr Director 2011-07-07 2021-06-08
CROZIER, Michael Julian Director 2010-12-01 2017-03-23
DAVIES, Dawn Carol Director 2004-12-02 2009-12-02
DUMSDAY, Yvonne Director 1991-07-19 2008-06-27
EDWARDS, Raymond Brunton Director 2014-07-03 2018-07-04
EDWARDS, Raymond Brunton Director 2002-06-28 2010-12-31
ELLIS, Brian Director 2008-02-06 2010-03-10
FINNIE, Robert Marshall, Dr Director 2006-06-28 2011-07-07
FISHER, David Director 1992-09-26 1993-01-30
GHOSH, Tamar Anna Director 2011-12-09 2017-06-03
GOLDWATER, Michael Harry Director 1997-08-13 2002-11-29
GOLDWATER, Michael Harry Director 1992-09-26 1994-06-15
HOWELLS, Gaenor Wyn Director 2010-10-04 2021-03-24
HUGHES, Elizabeth Ann, Dr Director 1993-03-29 2012-06-28
JARVIS, Sarah Caroline, Dr Director 2008-06-27 2008-06-28
KENNERLEY, Tricia Director 2014-12-17 2024-04-19
KERR, Alexander George Director 2017-11-10 2018-08-02
KIM, Nicole Sunghan Director 2020-03-12 2023-05-23
LAKER, Michael Francis, Dr Director 2013-03-28 2014-02-05
LAZARUS, Edward Alfred Director 1997-11-01 2007-06-28
LAZARUS, Edward Alfred Director 1991-07-19 1992-09-26
LEEDS, Anthony Richard, Dr Director 2006-03-06 2011-07-07
LEES, Tim Director 2008-02-06 2010-04-26
MACKNESS, Michael Ian, Doctor Director 2002-06-28 2004-07-01
MALING, Cordelia Director 1992-03-27 1995-09-09
MERCHANT, Zoe Anne Director 2013-07-03 2020-03-05
MORRELL, Jonathan Mark, Doctor Director 1999-11-26 2004-07-01
MORRIS, Clifford Laurence Director 1991-07-19 1997-02-03
MYOTT, Sophie Ruth Director 2018-07-24 2020-12-02
NEELY, Robert Dermot Garmany, Doctor Director 2002-06-28 2008-06-27
NEIL, Hugh Andrew Wade, Professor Director 2004-12-02 2010-07-07
PETER, John Beverly, Dr Director 2010-10-04 2012-04-10
RECKLESS, John Phillip David, Dr Director 2002-06-28 2018-07-04
RECORD, Neil Peter Director 1991-07-19 1992-09-26
SATTAR, Naveed, Professor Director 2002-06-28 2006-06-29
SEED, Mary, Dr Director 2001-07-16 2003-07-04
SIERWALD, Robert Christopher Director 1991-09-14 1997-11-22
SIVERS, Francesca Caroline, Dr Director 2002-07-16 2006-06-29
SMITH, Alan Richard Director 1991-07-19 2004-07-01
WEST, Lynn Director 2006-10-16 2010-12-31
WIERZBICKI, Anthony Stanislav, Dr Director 2002-06-28 2008-06-27
WINDER, Anthony Frederick, Professor Director 1999-11-26 2001-12-06
WINDER, Anthony Frederick, Professor Director 1991-07-19 1992-09-26
WRIGHT, John William, Doctor Director 2002-06-28 2007-09-07

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Dr Peter Huw Green Individual Significant influence, significant-influence-or-control-as-trust, significant-influence-or-control-as-firm 2020-06-30 Ceased 2025-06-12
Mr Neil Robert Phipps Individual Significant influence 2018-08-02 Ceased 2025-06-12
Mr Alexander George Kerr Individual significant-influence-or-control-as-trust 2017-11-10 Ceased 2018-08-02
Mr Stephen David Boley Individual Significant influence 2016-07-28 Ceased 2020-06-30
Mr Raymond Brunton Edwards Individual Significant influence 2016-07-28 Ceased 2018-07-04

Filing timeline

Last 20 of 228 total filings

Date Type Category Description
2025-10-27 CH01 officers Change person director company with change date PDF
2025-10-08 AA accounts Accounts with accounts type group
2025-07-31 RP04AP01 officers Second filing of director appointment with name PDF
2025-07-21 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-07-14 PSC08 persons-with-significant-control Notification of a person with significant control statement PDF
2025-06-12 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2025-06-12 PSC07 persons-with-significant-control Cessation of a person with significant control PDF
2025-01-21 AP01 officers Appoint person director company with name date PDF
2025-01-21 CH01 officers Change person director company with change date PDF
2024-09-21 AA accounts Accounts with accounts type group
2024-07-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-05-20 CH03 officers Change person secretary company with change date PDF
2024-04-23 TM01 officers Termination director company with name termination date PDF
2024-01-19 CH01 officers Change person director company with change date PDF
2023-08-23 AA accounts Accounts with accounts type group
2023-07-20 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-07-20 TM01 officers Termination director company with name termination date PDF
2023-05-26 TM01 officers Termination director company with name termination date PDF
2022-10-17 CH01 officers Change person director company with change date PDF
2022-09-16 CH01 officers Change person director company with change date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
7

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-02-28 vs 2024-02-29

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers

Official Companies House page